Retatrutide, from Soma Pharmaceuticals , is gaining increasing attention as a novel method for metabolic control . This dual-action compound combines the activity of a GLP-1 receptor activator and a GIP receptor agonist , aiming to effectively promote weight loss but also improve related metaboli